Liraglutide (Victoza) vs. Dulaglutide (Trulicity): A GLP-1 Receptor Agonist Comparison
Liraglutide (Victoza) and Dulaglutide (Trulicity) are both injectable medications in the GLP-1 receptor agonist class, used to help adults and children aged 10 and older with type 2 diabetes manage their blood sugar. Both drugs also offer cardiovascular benefits for adults. Patients often compare these medications due to their similar mechanisms and uses.
Side-by-Side Comparison
| Category | Liraglutide | Dulaglutide |
|---|---|---|
| Drug Class | GLP-1 Receptor Agonist | GLP-1 Receptor Agonist |
| Primary Use | Improves blood sugar control and reduces risk of major cardiovascular events in type 2 diabetes. | Improves blood sugar control and reduces risk of major cardiovascular events in type 2 diabetes. |
| Dosing Frequency | Daily injection | Once-weekly injection |
| Key Advantage | Longer history of use, available for children aged 10 and older. | Convenient once-weekly dosing, available for children aged 10 and older. |
| Main Limitation | Requires daily administration. | May have a slightly higher risk of thyroid C-cell tumors (seen in animal studies). |
| Cardiovascular Benefit | Reduces risk of major adverse cardiovascular events (CV death, non-fatal MI, non-fatal stroke). | Reduces risk of major adverse cardiovascular events (CV death, non-fatal MI, non-fatal stroke). |
| When to Choose | Your doctor might prefer Liraglutide if you need a daily medication that has a well-established safety profile, or if a daily routine fits better into your lifestyle. It's also a good option for patients who might benefit from a more frequent dose adjustment if needed. | Dulaglutide may be preferred if you are looking for the convenience of a once-weekly injection, which can improve adherence and ease of use. This can be particularly beneficial for busy individuals or those who prefer fewer injections. |
| Side Effects | Both medications share common side effects such as nausea, vomiting, diarrhea, and constipation, especially when starting treatment. Both also carry warnings for acute pancreatitis. Dulaglutide has a boxed warning regarding thyroid C-cell tumors based on animal studies, which is not as prominent for Liraglutide. | |
| Cost | Both Liraglutide (Victoza) and Dulaglutide (Trulicity) are brand-name medications and do not have generic versions available. Their costs can be high and vary based on insurance coverage. |
Bottom Line
Both Liraglutide (Victoza) and Dulaglutide (Trulicity) are effective GLP-1 receptor agonists for managing type 2 diabetes and reducing cardiovascular risk. The main difference often comes down to dosing frequency – daily for Liraglutide versus once-weekly for Dulaglutide – and specific patient preferences or medical considerations. Always discuss with your doctor which option is best for your individual health needs.
Liraglutide Overview
Liraglutide (Victoza) is a type of medicine that mimics a natural hormone in your body. It is prescribed to help adults and children aged 10 and older with type 2 diabetes manage their blood sugar levels, and it can also lower the risk of serious heart problems like heart attack or stroke in adults with type 2 diabetes and existing heart disease. It works by helping your body release insulin when needed and reducing the amount of sugar your liver makes.
Full Liraglutide guide →Dulaglutide Overview
Trulicity (dulaglutide) is a medication in a class called GLP-1 receptor agonists. It is used alongside diet and exercise to help adults and children aged 10 and older with type 2 diabetes manage their blood sugar levels. Additionally, for adults with type 2 diabetes who have heart disease or risk factors, Trulicity can help lower their risk of serious heart problems like heart attack or stroke.
Full Dulaglutide guide →Compare prices for Liraglutide and Dulaglutide
Check real-time pharmacy prices before you fill — free, no account needed.
Protect your muscle mass on GLP-1 medications
GLP-1 medications can cause up to 39% muscle loss alongside fat. Zova's AI-powered protocol — backed by Lancet Diabetes & Endocrinology research — reduces that to just 8.7% through leucine tracking and injection-day adaptive nutrition.
No credit card. No commitment.
Medical Disclaimer
The information on RxGuide is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, pharmacist, or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.